New Insights in the Pathogenesis of Multiple Sclerosis—Role of Acrolein in Neuronal and Myelin Damage
Abstract
:1. Introduction
2. Pathogenesis
3. Oxidative Stress
4. Acrolein
5. Demyelination
6. Axonal Injury
7. Mitochondrial Dysfunction
8. Acrolein Scavenging—A Novel Treatment Strategy for MS
9. Concluding Remarks
Acknowledgments
Conflicts of Interest
References
- Block, M.L.; Hong, J.S. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog. Neurobiol 2005, 76, 77–98. [Google Scholar]
- Trapp, B.D.; Nave, K.A. Multiple sclerosis: An immune or neurodegenerative disorder? Annu. Rev. Neurosci 2008, 31, 247–269. [Google Scholar]
- Hohlfeld, R. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 1997, 120, 865–916. [Google Scholar]
- Bitsch, A.; Schuchardt, J.; Bunkowski, S.; Kuhlmann, T.; Bruck, W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000, 123, 1174–1183. [Google Scholar]
- Compston, A.; Coles, A. Multiple sclerosis. Lancet 2008, 372, 1502–1517. [Google Scholar]
- Frischer, J.M.; Bramow, S.; Dal-Bianco, A.; Lucchinetti, C.F.; Rauschka, H.; Schmidbauer, M.; Laursen, H.; Sorensen, P.S.; Lassmann, H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009, 132, 1175–1189. [Google Scholar]
- Roach, E.S. Is multiple sclerosis an autoimmune disorder? Arch. Neurol 2004, 61, 1615–1616. [Google Scholar]
- Weiner, H.L. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch. Neurol 2004, 61, 1613–1615. [Google Scholar]
- Lucchinetti, C.; Bruck, W.; Parisi, J.; Scheithauer, B.; Rodriguez, M.; Lassmann, H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol 2000, 47, 707–717. [Google Scholar]
- Oksenberg, J.R.; Panzara, M.A.; Begovich, A.B.; Mitchell, D.; Erlich, H.A.; Murray, R.S.; Shimonkevitz, R.; Sherritt, M.; Rothbard, J.; Bernard, C.C.; et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993, 362, 68–70. [Google Scholar]
- Zhang, J.; Markovic-Plese, S.; Lacet, B.; Raus, J.; Weiner, H.L.; Hafler, D.A. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med 1994, 179, 973–984. [Google Scholar]
- Frohman, E.M.; Racke, M.K.; Raine, C.S. Multiple sclerosis—The plaque and its pathogenesis. N. Engl. J. Med 2006, 354, 942–955. [Google Scholar]
- Trapp, B.D.; Peterson, J.; Ransohoff, R.M.; Rudick, R.; Mork, S.; Bo, L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med 1998, 338, 278–285. [Google Scholar]
- Gold, R.; Linington, C.; Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129, 1953–1971. [Google Scholar]
- Bragt, P.C.; Bonta, I.L. Oxidant stress during inflammation: Anti-inflammatory effects of antioxidants. Agents Actions 1980, 10, 536–539. [Google Scholar]
- Gilgun-Sherki, Y.; Melamed, E.; Offen, D. The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy. J. Neurol 2004, 251, 261–268. [Google Scholar]
- Luo, J.; Shi, R. Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem. Int 2004, 44, 475–486. [Google Scholar]
- Smith, K.J.; Kapoor, R.; Felts, P.A. Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol 1999, 9, 69–92. [Google Scholar]
- Calingasan, N.Y.; Uchida, K.; Gibson, G.E. Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer’s disease. J. Neurochem 1999, 72, 751–756. [Google Scholar]
- Daimon, M.; Sugiyama, K.; Kameda, W.; Saitoh, T.; Oizumi, T.; Hirata, A.; Yamaguchi, H.; Ohnuma, H.; Igarashi, M.; Kato, T. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. Endocrine J 2003, 50, 61–67. [Google Scholar]
- Feng, Z.; Hu, W.; Hu, Y.; Tang, M.S. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl. Acad. Sci. USA 2006, 103, 15404–15409. [Google Scholar]
- Srivastava, S.; Sithu, S.D.; Vladykovskaya, E.; Haberzettl, P.; Hoetker, D.J.; Siddiqui, M.A.; Conklin, D.J.; D’Souza, S.E.; Bhatnagar, A. Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice. Atherosclerosis 2011, 215, 301–308. [Google Scholar]
- Takabe, W.; Niki, E.; Uchida, K.; Yamada, S.; Satoh, K.; Noguchi, N. Oxidative stress promotes the development of transformation: Involvement of a potent mutagenic lipid peroxidation product, acrolein. Carcinogenesis 2001, 22, 935–941. [Google Scholar]
- Esterbauer, H.; Schaur, R.J.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med 1991, 11, 81–128. [Google Scholar]
- Luo, J.; Shi, R. Acrolein induces oxidative stress in brain mitochondria. Neurochem. Int 2005, 46, 243–252. [Google Scholar]
- Shi, R.; Rickett, T.; Sun, W. Acrolein-mediated injury in nervous system trauma and diseases. Mol. Nutr. Food Res 2011, 55, 1320–1331. [Google Scholar]
- Leung, G.; Sun, W.; Zheng, L.; Brookes, S.; Tully, M.; Shi, R. Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune encephalomyelitis mouse. Neuroscience 2011, 173, 150–155. [Google Scholar]
- Lovell, M.A.; Markesbery, W.R. Amyloid beta peptide, 4-hydroxynonenal and apoptosis. Curr. Alzheimer Res 2006, 3, 359–364. [Google Scholar]
- Lovell, M.A.; Xie, C.; Markesbery, W.R. Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 2001, 22, 187–194. [Google Scholar]
- Shi, R.; Luo, J.; Peasley, M. Acrolein inflicts axonal membrane disruption and conduction loss in isolated guinea-pig spinal cord. Neuroscience 2002, 115, 337–340. [Google Scholar]
- Acrolein and/or Formaldehyde. Available online: https://www.osha.gov/dts/sltc/methods/organic/org052/org052.html (access on 25 September 2013).
- Kehrer, J.P.; Biswal, S.S. The molecular effects of acrolein. Toxicol. Sci 2000, 57, 6–15. [Google Scholar]
- Ghilarducci, D.P.; Tjeerdema, R.S. Fate and effects of acrolein. Rev. Environ. Contam. Toxicol 1995, 144, 95–146. [Google Scholar]
- Jensen, J.M.; Shi, R. Effects of 4-aminopyridine on stretched mammalian spinal cord: The role of potassium channels in axonal conduction. J. Neurophysiol 2003, 90, 2334–2340. [Google Scholar]
- Shi, Y.; Sun, W.; McBride, J.J.; Cheng, J.X.; Shi, R. Acrolein induces myelin damage in mammalian spinal cord. J. Neurochem 2011, 117, 554–564. [Google Scholar]
- Sun, W.; Smith, D.; Fu, Y.; Cheng, J.X.; Bryn, S.; Borgens, R.; Shi, R. Novel potassium channel blocker, 4-AP-3-MeOH, inhibits fast potassium channels and restores axonal conduction in injured guinea pig spinal cord white matter. J. Neurophysiol 2011, 103, 469–478. [Google Scholar]
- Morell, P.; Quarles, R.H. Myelin Formation, Structure and Biochemistry. In Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, 6th ed; Siegel, G.J., Agranoff, B.W., Albers, R.W., Fisher, S.K., Uhler, M.D., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 1999. [Google Scholar]
- Poliak, S.; Peles, E. The local differentiation of myelinated axons at nodes of Ranvier. Nat. Rev. Neurosci 2003, 4, 968–980. [Google Scholar]
- Liu-Snyder, P.; McNally, H.; Shi, R.; Borgens, R.B. Acrolein-mediated mechanisms of neuronal death. J. Neurosci. Res 2006, 84, 209–218. [Google Scholar]
- Goll, D.E.; Thompson, V.F.; Li, H.; Wei, W.; Cong, J. The calpain system. Physiol. Rev 2003, 83, 731–801. [Google Scholar]
- Wang, K.K. Calpain and caspase: Can you tell the difference? Trends Neurosci 2000, 23, 20–26. [Google Scholar]
- Blight, A.R. Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res. Bull 1989, 22, 47–52. [Google Scholar]
- Shi, R.; Blight, A.R. Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord. Neuroscience 1997, 77, 553–562. [Google Scholar]
- Waxman, S.G. Demyelination in spinal cord injury and multiple sclerosis: What can we do to enhance functional recovery? J. Neurotrauma 1992, 9, S105–S117. [Google Scholar]
- Waxman, S.G.; Utzschneider, D.A.; Kocsis, J.D. Enhancement of action potential conduction following demyelination: Experimental approaches to restoration of function in multiple sclerosis and spinal cord injury. Prog. Brain Res 1994, 100, 233–243. [Google Scholar]
- Trapp, B.D.; Ransohoff, R.; Rudick, R. Axonal pathology in multiple sclerosis: Relationship to neurologic disability. Curr. Opin. Neurol 1999, 12, 295–302. [Google Scholar]
- Trapp, B.D.; Stys, P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009, 8, 280–291. [Google Scholar]
- Hamann, K.; Nehrt, G.; Ouyang, H.; Duerstock, B.; Shi, R. Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord. J. Neurochem 2008, 104, 708–718. [Google Scholar]
- Cadenas, E.; Davies, K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med 2000, 29, 222–230. [Google Scholar]
- Lenaz, G.; Bovina, C.; D’Aurelio, M.; Fato, R.; Formiggini, G.; Genova, M.L.; Giuliano, G.; Merlo Pich, M.; Paolucci, U.; Parenti Castelli, G.; et al. Role of mitochondria in oxidative stress and aging. Ann. N. Y. Acad. Sci 2002, 959, 199–213. [Google Scholar]
- Biagini, R.E.; Toraason, M.A.; Lynch, D.W.; Winston, G.W. Inhibition of rat heart mitochondrial electron transport in vitro: Implications for the cardiotoxic action of allylamine or its primary metabolite, acrolein. Toxicology 1990, 62, 95–106. [Google Scholar]
- Picklo, M.J.; Montine, T.J. Acrolein inhibits respiration in isolated brain mitochondria. Biochim. Biophys. Acta 2001, 1535, 145–152. [Google Scholar]
- Vaishnav, R.A.; Singh, I.N.; Miller, D.M.; Hall, E.D. Lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function. J. Neurotrauma 2010, 27, 1311–1320. [Google Scholar]
- Fiore, C.; Trezeguet, V.; le Saux, A.; Roux, P.; Schwimmer, C.; Dianoux, A.C.; Noel, F.; Lauquin, G.J.; Brandolin, G.; Vignais, P.V. The mitochondrial ADP/ATP carrier: Structural, physiological and pathological aspects. Biochimie 1998, 80, 137–150. [Google Scholar]
- Klingenberg, M.; Nelson, D.R. Structure-function relationships of the ADP/ATP carrier. Biochim. Biophys. Acta 1994, 1187, 241–244. [Google Scholar]
- Esposito, L.A.; Melov, S.; Panov, A.; Cottrell, B.A.; Wallace, D.C. Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl. Acad. Sci. USA 1999, 96, 4820–4825. [Google Scholar]
- Wallace, D.C. Mitochondrial diseases in man and mouse. Science 1999, 283, 1482–1488. [Google Scholar]
- Wallace, D.C. Mouse models for mitochondrial disease. Am. J. Med. Genet 2001, 106, 71–93. [Google Scholar]
- Hamann, K.; Shi, R. Acrolein scavenging: A potential novel mechanism of attenuating oxidative stress following spinal cord injury. J. Neurochem 2009, 111, 1348–1356. [Google Scholar]
- Facchinetti, F.A.F.; Geppetti, P.; Tarantini, F.; DiSerio, C.; Dragotto, A.; Gigli, P.M.; Catinella, S.; Patacchini, R. Alpha,beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am. J. Respir. Cell Mol. Biol 2007, 37, 617–623. [Google Scholar]
- Moretto, N.; Faccinetti, F.; Southworth, T.; Civelli, M.; Singh, D.; Patacchini, R. Alpha,beta-unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am. J. Physiol. Lung Cell Mol. Physiol 2009, 296, L839–L848. [Google Scholar]
- Park, Y.S.; Taniguchi, N. Acrolein indeuces inflammatory response underlying endothelial dysfunction: A risk factor for atherosclerosis. Ann. N. Y. Acad. Sci 2008, 1126, 185–189. [Google Scholar]
- Peasley, M.A.; Shi, R. Ischemic insult exacerbates acrolein-induced conduction loss and axonal membrane disruption in guinea pig spinal cord white matter. J. Neurol. Sci 2003, 216, 23–32. [Google Scholar]
- Barger, S.W.; Goodwin, M.E.; Porter, M.M.; Beggs, M.L. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem 2007, 101, 1205–1213. [Google Scholar]
- Lovell, M.A.; Xie, C.; Markesbery, W.R. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary cultures. Free Radic. Biol. Med 2000, 29, 714–720. [Google Scholar]
© 2013 by the authors; licensee MDPI, Basel, Switzerland This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Tully, M.; Shi, R. New Insights in the Pathogenesis of Multiple Sclerosis—Role of Acrolein in Neuronal and Myelin Damage. Int. J. Mol. Sci. 2013, 14, 20037-20047. https://doi.org/10.3390/ijms141020037
Tully M, Shi R. New Insights in the Pathogenesis of Multiple Sclerosis—Role of Acrolein in Neuronal and Myelin Damage. International Journal of Molecular Sciences. 2013; 14(10):20037-20047. https://doi.org/10.3390/ijms141020037
Chicago/Turabian StyleTully, Melissa, and Riyi Shi. 2013. "New Insights in the Pathogenesis of Multiple Sclerosis—Role of Acrolein in Neuronal and Myelin Damage" International Journal of Molecular Sciences 14, no. 10: 20037-20047. https://doi.org/10.3390/ijms141020037